Introduction
============

The "professional" phagocytes neutrophils, monocytes, eosinophils, and to a lesser extent macrophages, exhibit a profound burst of respiration when they ingest or attach to a microbe ([@B70]). This respiratory burst is non-mitochondrial and accomplished by the NADPH oxidase, NOX2, a short electron transport chain that is located in the wall of the phagocytic vacuole, that transfers electrons from NADPH in the cytosol onto oxygen in the vacuole, generating superoxide ([@B72]) (**Figure [1](#F1){ref-type="fig"}**). This electron transfer causes a large and rapid membrane depolarisation which will, itself, curtail further electron transport unless there is compensatory ion movement by the passage of cations into the vacuole and/or anions in the opposite direction ([@B27]).

![**Schematic representation of the proposed ion fluxes in the neutrophil phagocytic vacuole as a result of oxidase activation.** NOX2 is inhibited by DPI (diphenyleneiodonium), the HVCN1 channel is inhibited by zinc. A proportion of protons present in the cytosol is generated by the hexose monophosphate shunt (HMP). Adapted with permission from ([@B39]).](fphar-08-00094-g001){#F1}

About 90% of this charge compensation is accomplished by the influx of protons (H^+^) through the voltage-gated proton channel HVCN1 ([@B66]; [@B39]). Neutrophils are characterized by an abundance of cytoplasmic granules containing a plethora of enzymes and antimicrobial compounds which are released into the phagocytic vacuole. The cytoplasmic granules have an internal pH of approximately 5, that is maintained by the activity of a V-ATPase ([@B31]), and in the absence of an active oxidase the vacuole becomes acidic when these contents are released into it, as is the case in neutrophils from patients with Chronic Granulomatous Disease (CGD) ([@B39]), in whom the oxidase is defective. However, it has been recently demonstrated that in normal human neutrophils the vacuolar pH rises to approximately 9.0, a level at which it is maintained for 20--30 min ([@B39]), which is optimal for the killing and digestion of microbes by neutral proteases, including cathepsin G, and elastase ([@B39]). This elevation results from the consumption of protons within the vacuole by the protonation of O~2~^2-^ to form H~2~O~2~ (**Figure [1](#F1){ref-type="fig"}**).

If all the charge were compensated by protons, there would be no nett consumption of these ions, and protons from the fused granules would make the vacuole acidic. Therefore, charge compensation by ions other than protons must occur, and an intriguing aspect of this charge compensation is how the balance of fluxes of the different ions is accomplished to maintain the pH in a fairly precise band of alkalinity. This suggests regulatory gating of proton and non-proton charge compensating ion fluxes based upon pH and charge across the membrane.

To understand this process more fully it is important to identify and characterize the charge compensating channels. There is evidence for the movement of potassium ions (K^+^) into the neutrophil vacuole ([@B66]; [@B65]) and K^+^ channels have been implicated in eosinophils as important for superoxide production ([@B68]). There is conflicting evidence as to whether Cl^-^ passes into, and/or out of, the phagocytic vacuole. One of the theories concerning the killing of microbes involves the generation of hypochlorous acid (HOCl) by myeloperoxidase from H~2~O~2~ and Cl^-^ ([@B36]), which would require the passage of Cl^-^ into the vacuole. Some chloride will accumulate in the cytoplasmic granules ([@B74]) to compensate the charge generated when H^+^ are pumped into the granules by a V-ATPase to produce the low pH in these organelles (see **Figure [1](#F1){ref-type="fig"}**). Macrophages from CLIC1^-/-^ mice display a defect in phagosome acidification ([@B34]), and lysosome acidification is defective in alveolar macrophages from mice lacking the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) ([@B14]), a chloride channel, suggesting that these channels might transport Cl^-^ into granules in these cells. CFTR ([@B60], [@B59]), KCC3 ([@B77]), a K^+^-Cl^-^ co-transporter, and ClC3, a voltage-gated chloride channel that mediates the exchange of chloride ions for protons with a nett movement of Cl^-^ ([@B53]), have all been implicated as mechanisms for directly importing Cl^-^ into the vacuole. For CFTR and ClC3 to supply Cl^-^ to the vacuole, it would have to pass against a strong electrochemical gradient whereas KCC3 is electroneutral, so it would not directly act as a charge compensator. Others have suggested that Cl^-^ is passed in the opposite direction, out of the vacuole, through ClC3 ([@B37]; [@B51]).

When all electron transport is compensated by protons alone, no change in pH occurs in the vacuole because there is no nett consumption of protons to form H~2~O~2~ ([@B39]). In addition, and because protons are not osmotically active, there are no consequent changes in vacuolar volume. If, on the other hand, compensation is by ions other than protons, there is an elevation of the vacuolar pH, and changes in the volume will depend upon whether the nett flux of osmotically active ions is into, or out of, the vacuole. Therefore, conclusions as to the nature and direction of the movement of ions can be drawn from changes in pH and vacuolar volume. We recently developed an assay of these parameters, using *Candida albicans* labeled with the fluorescent ratiometric pH indicator seminaphthorhodafluor (SNARF)-1 ([@B39]). We reasoned that if a single, dominant, non-proton, compensating channel exists, then blocking, or genetically incapacitating, it might alter these parameters.

We tested a range of K^+^ and Cl^-^ channel blockers on normal human neutrophils, and also studied neutrophils from human subjects and mice in which specific ion channels had been deleted by gene targeting, or whose function had been compromised by natural mutation.

In addition to testing those channels previously associated with the oxidase in the literature, we prioritized channels according to mRNA expression levels in human neutrophils. To stress the system and promote ion flux through channels other than the HVCN1 proton channel, we performed studies on neutrophils from knock-out mice lacking both this channel and the channel under investigation, or we conducted the experiment in the presence of zinc chloride, which blocks HVCN1.

Materials and Methods {#s1}
=====================

Ethics Approval
---------------

This patient study was carried out in accordance with the recommendations of the Joint UCL/UCLH Committees on the Ethics of Human Research with written informed consent from all subjects. All subjects gave written informed consent in accordance with the Declaration of Helsinki. The protocol was approved by the Joint UCL/UCLH Committees on the Ethics of Human Research (Project numbers 02/0324 and 10/H0806/115).

This animal study was carried out in accordance with the recommendations of the United Kingdom Home Office. The protocol was approved by the United Kingdom Home Office (Project licence 70/8452).

Materials
---------

Balanced salt solution (BSS) buffer contained 156 mM NaCl, 3.0 mM KCl, 1.25mM KH~2~PO~4~, 2 mM MgSO~4~, 2 mM CaCl~2~, 10 mM glucose, 10 mM Hepes at pH 7.4. The KH~2~PO~4~ was removed in experiments employing Zn^2+^ which is precipitated by phosphate.

SNARF was from Invitrogen. Inhibitors were from either Sigma or Tocris and solubilized in dimethyl sulphoxide (DMSO) or 100% ethanol.

Measurements of Phagosomal pH and Area
--------------------------------------

These were measured as described previously ([@B39]). In brief: human neutrophils from peripheral blood were isolated by dextran sedimentation, centrifugation through Lymphoprep, and hypotonic lysis to remove erythrocytes. Neutrophils were resuspended in BSS buffer, and 200 μl of 4 to 5 × 10^6^ cells/ml were incubated for 45 min in the wells of a poly [L]{.smallcaps}-lysine coated Ibidi μ-Slide 8 well plate (Ibidi, Germany) to form an adherent cell monolayer.

The wells were washed twice with BSS buffer, and 200 μl buffer containing 1 μg carboxy SNARF-1, AM ester, acetate in 1 μl DMSO was added for 25 min to label the cytosol. After washing the wells twice, the incubation medium consisting of BSS buffer was added with or without the inhibitor.

Heat-killed *Candida* labeled with SNARF and opsonized with human serum IgG (Vivaglobin), were added to the wells. The plates were incubated at 37°C for 20 min, after which confocal images were obtained with a Zeiss 700 confocal microscope using a 63× oil immersion with excitation at 555 nm and emission at 560--600 nm and \>610 nm.

For neutrophils isolated from murine bone marrow, cells were flushed from the bone marrow of the tibias and femora with BSS buffer containing 0.5 mM EDTA, 5 IU/ml Heparin and 10% bovine serum albumin, and purified as described above. The *Candida* particles used for phagocytosis were opsonized with a mixture of normal mouse serum (VWR) and serum from mice immunized with *Candida* as described previously ([@B39]).

The vacuolar pH was measured using a custom macro within the imaging software ImageJ ([@B71]). The SNARF fluorescence ratio (SFR) values were converted to pH using the standard curves as described by [@B39]: the fluorescence ratios of extracellular SNARF-labeled *Candida* were measured in different buffer solutions (100 mM KCl with 50 mM buffer salt) from pH 3--13 to construct two standard curves; the fluorescence ratios of SNARF-labeled *Candida* engulfed by human neutrophils were measured after the phagocytosing cells were then subjected to the same buffers with 0.3% saponin; cytoplasmic pH was measured in human neutrophils in the same buffers with nigericin ([@B55]). The outer perimeter of vacuoles containing one visible yeast particle was manually delineated. The cross-sectional area was then determined with ImageJ.

Analysis of Phagosomal pH and Area
----------------------------------

We found that human vacuolar pH measurements were distributed into two main groups, alkaline, and more acidic. This can be explained because vacuolar closure is incomplete in some cases, and because the timing of particle uptake was not synchronized, so some would have been older than others. In addition, as seen in Figure 3E of [@B39] representing a time course of human neutrophil phagocytosis, some vacuoles returned to more acidic levels within 30 min, after initially becoming alkaline.

Due to our interest in the factors influencing the alkalinisation of the vacuole, we undertook a cluster analysis of the control vacuolar data, using the package 'Mclust' ([@B19]) in the programming software R ([@B64]). This fits data into Gaussian finite mixture models with an algorithm for model-based clustering, classification, and density estimation. The maximum measurement of the lower ratio acidic group was calculated, and points below this value were removed (see figure legends for exact number). HVCN1^-/-^ murine neutrophils also have a smaller subset of acidic vacuoles which were removed by the same method. This particular analysis was not necessary for wild type mouse neutrophil vacuolar pH as they tended to be more acidic and not readily separated into two clusters.

For both vacuolar pH and area, the measurements have been displayed as scatter plots with overlaying boxplots, which show the median and upper and lower quartiles. Linear model analysis, using the lm function in the programming software R ([@B64]), was used to test the statistical significance of the comparison between the control condition and that in the presence of the inhibitor, or in cells with an altered genetic background.

Measurement of Respiratory Burst
--------------------------------

Respiration was measured as described previously ([@B39]) with the Seahorse Bioscience XFe24 Extracellular Flux Analyzer. A calibration plate was first run through the machine according to the manufacturer's instructions. The assay plate was pre-treated with 50 μl of 22.4 μg/ml Cell-Tak (BD Bioscience) in PBS in each well for 45 min at room temperature and washed twice with sterile water. Hundred microliter of a suspension of 4 × 10^7^/ml human neutrophils, resuspended in the BSS buffer lacking phosphate, was added to each well. The plate was centrifuged first at 450 g for 1 min and then for a minute in the opposite orientation. The medium was replaced with 600 μl of the BSS buffer lacking phosphate with or without the inhibitor. 4 × 10^6^ in 10 μl of opsonized *Candida* was added to each well then readings commenced. The inhibitor was present in the medium before and after the addition of *Candida* so it could access both cytoplasmic and vacuolar membranes. The oxygen consumption was calculated as the integral of the rate of oxygen consumption for 15 min

Measurement of oxygen consumption was conducted on mouse neutrophils isolated from the peritoneal cavity after stimulation by thioglycolate (as described previously; [@B39]), as described above using 4 × 10^6^ cells/ml.

Statistical analysis was calculated in Excel by Student's *t*-test of paired means across the individual wells within each experiment and across repeats of the same experiment.

Gene Expression Profiling of Human Neutrophils
----------------------------------------------

Gene expression data from resting human neutrophils from healthy individuals were isolated from nine individual publically available studies on the Gene Expression Omnibus ([@B17]) (Supplementary Table [S2](#SM2){ref-type="supplementary-material"}). There were data from a total of 66 samples, a mean of seven (minimum three) per study. Data were analyzed with R ([@B64]). For all but one dataset, raw data were processed using the Affy package ([@B21]). For one dataset, pre-processed data were used. Raw data were imported using ReadAffy and normalized with Robust Multi-array Average. Detected probes were then identified per sample using pa.calls from the panp package ([@B84]). Probes that were detected in at least 50% of the individual samples within each data set were retained. Genes within a gene family ([@B23]) containing the terms channel or carrier or those with a GO term containing one of the following were retained: potassium, sodium, chloride, channel, or exchanger. Control genes that were known to be involved in neutrophil function or markers of possible contaminating cells were also retained. Within each dataset, the relative centile expression of the retained genes from all detected genes was determined. The summary statistics across the nine studies were combined by gene and the mean calculated. It is conceivable that a putative channel or exchanger involved in neutrophil charge compensation could have been inappropriately omitted by the requirement for either the gene family or GO term to be matched; however, this approach was utilized as a means of reducing the search space to contain a manageable number of the most likely candidates.

Sources of Neutrophils
----------------------

### Mutant Mice

We studied knockout mice lacking CLIC1 ([@B63]), KCC3 ([@B44]), ClC3 ([@B75]), KCNQ1 ([@B20]), KCNE3 ([@B67]), KCNJ15 (MRC Harwell), TRPM2 ([@B87]), TRPV2 ([@B43]), a mouse lacking the combination of TRPC1, TRPC3, TRPC5 and TRPC6 and a dual KO of TRPV1 and TRPA1, SLC26A6. We also studied a mouse with a loss of function mutation in ClC7 ([@B2]). We bred the HVCN1/ CLIC1, HVCN1/ ClC3, HVCN1/KCC3, HVCN1/ TRPM2, HVCN1/ KCNQ1, and TRPM2/KCNQ1 double knock-outs. The sources of all mice are provided in the Acknowledgments section.

### Patients with Channelopathies

We studied human cells from individuals with mutations in CFTR (two patients both homozygous ΔF508), BEST1 (two heterozygote patients with Best vitelliform macular dystrophy due to mutations in BEST1: (patient 1) a 25 year old female heterozygous for a missense (p.H178P) and frameshift (p.Tyr347LeufsX54) mutations, and (patient 2) a 55 year-old male with total allelic deletion p.Pro152Ala,p.Ala195Val). For patients with a mutation in ClC7 (Albers-Schönberg disease; patient 1 with homozygous novel missense change c.1120G \> A, p.(Glu374Lys) in exon 13; patient 2 with a homozygous novel missense change at c.2332-IG \> A in intron 24 which lead to defective splicing of exon 24 and 25). One patient with a mutation in MCOLN1 (Mucolipidosis type IV c.236_237ins93 from NADH dehydrogenase 5 99-192 and R403C) was recruited.

Results
=======

The Effect of Ion Channel Inhibitors on Human Vacuolar pH and Swelling
----------------------------------------------------------------------

### Chloride Channel Inhibitors Cause Significant Vacuolar Acidification

In human cells, the broad spectrum chloride channel blockers DCPIB and FFA caused the most significant abrogation of vacuolar alkalinisation. Of the many classical ion channel inhibitors tested (see Supplementary Table [S1](#SM1){ref-type="supplementary-material"}), DCPIB was the most effective in this manner by decreasing the pH from ∼ 9.0 to 8.5 (**Figure [2A](#F2){ref-type="fig"}**). FFA also caused a smaller, but still statistically significant, decrease to ∼ pH 8.8. Zn^2+^ used at 100 μM increase the vacuolar pH to ∼ pH 9.2. The elevation in pH and vacuolar area induced by Zn^2+^ was still much less than that resulting from complete elimination of the channel in the HVCN1^-/-^ cells, indicating that Zn^2+^ only caused a partial blockage.

![**The effect of DCPIB and FFA with and without zinc on human vacuolar pH (A)** and area **(B)**. The acidic vacuole population was removed as described in the methods section; the vacuoles excluded are those with a SNARF Fluorescence ratio (SFR) below 1.36. Each point represents an individual measurement (see **Table [1](#T1){ref-type="table"}** for the exact number of measurements and statistics); each condition has an overlaying boxplot showing the median and interquartile range. DCPIB (20 μM), FFA (100 μM), Zn (Zn^2+^ 100 μM), D+Zn (DCPIB with Zn^2+^), F+Zn (FFA with Zn^2+^). Differences from control neutrophils: ^∗^*p* \< 0.05, ^∗∗^*p* \< 0.01, ^∗∗∗^*p* \< 0.001. Differences from neutrophils incubated with Zn2+: †*p* \< 0.05, ††*p* \< 0.01, †††*p* \< 0.001.](fphar-08-00094-g002){#F2}

In the presence of 100 μM Zn^2+^, DCPIB and FFA also reduced the vacuolar pH to lower than the Zn^2+^ control; ∼ pH 8.8 and 9.0 respectively (**Figure [2A](#F2){ref-type="fig"}**). These findings suggest that a Cl^-^ channel is likely to be involved in charge compensation.

### Chloride Channel Inhibitors Increase Vacuolar Swelling

DCPIB alone had no effect on the vacuolar area (**Figure [2B](#F2){ref-type="fig"}**), whereas FFA increased this slightly from 13.4 to 13.9 μm^2^. However, the *p*-value of 0.016 was relatively insignificant when adjusting for multiple testing -- we investigated nearly 70 different ion channel inhibitors which naturally lowers the significance threshold when using the Bonferroni correction. Zn^2+^ alone increased swelling to 13.9 μm^2^ but had a more statistically significant *p*-value of 1.25 × 10^-8^; see **Table [1B](#T1){ref-type="table"}** for more detailed statistics. When Zn^2+^ and FFA were combined the median vacuolar size was not significantly different from Zn^2+^ alone, however, when DCPIB was combined with Zn^2+^ vacuolar size increased dramatically to 15.8 μm^2^. The increased swelling of vacuoles induced by chloride channel blockers suggests that chloride is being retained within the vacuole and/or its export replaced, at least in part, by the influx of an osmotically active cation.

###### 

Vacuolar pH **(A)** and area **(B)** experimental measurements and statistics for chloride channel inhibitors.

  \(A\) Vacuolar SNARF ratio                                                                                                                                                             
  ---------------------------- ------------- ------------------- ----------------------------- --------------- ------------------- ------------------------------- --------------- ----- ----------------
  ***N***                      **Control**   **No. of points**   **Control median (SFR/pH)**   **Inhibitor**   **No. of points**   **Inhibitor median (SFR/pH)**   ***p*-value**         
                                                                                                                                                                                         
  11                           Control       875                 2.0                           9.0             Zinc                1014                            2.2             9.2   7.75 × 10^-13^
  3                            Control       202                 1.9                           9.0             DCPIB               85                              1.5             8.5   3.53 × 10^-12^
  4                            Control       330                 2.1                           9.1             FFA                 333                             1.8             8.8   3.73 × 10^-24^
  3                            Zinc          227                 2.2                           9.2             DCPIB + zinc        187                             1.7             8.8   1.17 × 10^-14^
  4                            Zinc          353                 2.2                           9.2             FFA + zinc          443                             1.9             9.0   2.32 × 10^-25^
                                                                                                                                                                                         
  **(B) Vacuolar area**                                                                                                                                                                  
                                                                                                                                                                                         
  ***N***                      **Control**   **No. of points**   **Control median (±*SD*)**    **Inhibitor**   **No. of points**   **Inhibitor median (±*SD*)**    ***p*-value**         
                                                                                                                                                                                         
  11                           Control       1537                13.2 (3.8)                    Zinc            1574                13.9 (4.4)                      1.25 × 10^-8^         
  3                            Control       454                 13.4 (3.7)                    DCPIB           429                 13.7 (3.4)                      0.145                 
  4                            Control       523                 13.4 (3.8)                    FFA             576                 13.9 (4.1)                      0.016                 
  3                            Zinc          380                 13.6 (4.8)                    DCPIB + zinc    406                 15.8 (4.7)                      2.52 × 10^-7^         
  4                            Zinc          560                 13.8 (3.9)                    FFA + zinc      581                 14.3 (3.6)                      0.093                 

N = number of experiments performed, no. of points describes the total number of individual measurements. The control and corresponding knockout medians are accompanied with the SFR and converted vacuolar pH and standard deviation (SD) for the vacuolar area.

### Potassium Channel Inhibitors Cause a Small Reduction in Vacuolar pH

Anandamide is a non-specific blocker of voltage-gated and two-pore K^+^ channels. It caused a slight vacuolar acidification alone (**Figure [3A](#F3){ref-type="fig"}**), from ∼ pH 9.1 to 8.9, and also when combined with Zn^2+^, from ∼ pH 9.2 to 9.0. Quinidine only caused a small drop in vacuolar pH when combined with Zn^2+^ (∼ pH 9.2 to 9.1). It is also a broad-spectrum inhibitor of several potassium channels, sodium channels, and the swell-activated chloride channel (ICI~swell~). However, the effect of both these inhibitors on vacuolar pH was much smaller than with DCPIB or FFA, **Table [2](#T2){ref-type="table"}** describes the complete measurements and statistics. **Table [3](#T3){ref-type="table"}** lists the purported sites of inhibition and activation of the other compounds tested and their general effects on the vacuolar parameters.

![**The effect of anandamide and quinidine with and without Zn^2+^ on vacuolar pH (A)** and area **(B).** The acidic vacuoles excluded are those with a SFR below 1.31. Each square represents an individual measurement; each condition has an overlaying boxplot showing the median and interquartile range. More detailed statistics are provided in **Table [2](#T2){ref-type="table"}**. A (anandamide 100 μM), Q (quinidine 100 μM), Zn (Zn^2+^ 100 μM). Differences from control neutrophils: ^∗^*p* \< 0.05, ^∗∗^*p* \< 0.01, ^∗∗∗^*p* \< 0.001. Differences from neutrophils incubated with Zn^2+^: †*p* \< 0.05, ††*p* \< 0.01, †††*p* \< 0.001.](fphar-08-00094-g003){#F3}

###### 

Vacuolar pH **(A)** and area **(B)** experimental measurements and statistics for potassium channel inhibitors.

  \(A\) Vacuolar SNARF ratio                                                                                                                                                                  
  ---------------------------- ------------- ------------------- ----------------------------- ------------------- ------------------- ------------------------------- ---------------- ----- ---------------
  ***N***                      **Control**   **No. of points**   **Control median (SFR/pH)**   **Inhibitor**       **No. of points**   **Inhibitor median (SFR/pH)**   ***p*-value**          
                                                                                                                                                                                              
  3                            Control       271                 2.1                           9.1                 Anandamide          230                             1.8              8.9   1.64 × 10^-5^
  4                            Control       342                 1.9                           8.9                 Quinidine           348                             2.0              9.1   0.264
  3                            Zinc          308                 2.2                           9.2                 Anandamide + zinc   128                             1.9              9.0   1.12 × 10^-6^
  4                            Zinc          372                 2.2                           9.2                 Quinidine + zinc    461                             2.1              9.1   3.88 × 10^-6^
                                                                                                                                                                                              
  **(B) Vacuolar area**                                                                                                                                                                       
                                                                                                                                                                                              
  ***N***                      **Control**   **No. of points**   **Control median (±*SD*)**    **Inhibitor**       **No. of points**   **Inhibitor median (±*SD*)**    ***p*-value**          
                                                                                                                                                                                              
  3                            Control       336                 12.8 (3.5)                    Anandamide          346                 12.8(3.6)                       0.085                  
  4                            Control       374                 13.2 (3.9)                    Quinidine           484                 13.1(3.4)                       0.364                  
  3                            Zinc          392                 14.2 (4.0)                    Anandamide + zinc   324                 12.6 (2.7)                      6.11 × 10^-14^         
  4                            Zinc          470                 13.9 (4.0)                    Quinidine + zinc    522                 13.2(3.2)                       2.54 × 10^-4^          

N = number of experiments performed, no. of points describes the total number of individual measurements. The control and corresponding knockout medians are accompanied with the SFR and converted vacuolar pH and standard deviation (SD) for the vacuolar area.

###### 

Summary of the effects of specified compounds with their reported sites of activity, and the general effect on vacuolar pH and area in human neutrophils.

  Compound     Sites of inhibition (specific channel/transporter or conductance)                                                Sites of activation   Effect on neutrophils compared to control   
  ------------ ---------------------------------------------------------------------------------------------------------------- --------------------- ------------------------------------------- -------------
  DCPIB        ICI~swell~ ([@B11]), Kir ([@B13]), KCC3 ([@B1])                                                                  TREK-1,-2 ([@B52])    ↓ pH                                        ↓ pH ↑ area
  FFA          ICI~swell~ ([@B35]), Ca^2+^ activated Cl^-^ ([@B41]; [@B57]), TRP ([@B24])                                       TREK-1,-2 ([@B78])    ↓ pH ↑ area                                 ↓ pH
  Anandamide   TASK-1, -3 (2P K channels) ([@B45]), Kv channels ([@B62])                                                        TRPV1 ([@B33])        ↓ pH                                        ↓ pH ↓ area
  Quinidine    Na^+^ channels ([@B28]), KCa channels ([@B30]) Kv channels ([@B89]) 2P K channels ([@B61]) ICI~swell~ ([@B82])                                                                     ↓ pH ↓ area

### Potassium Channel Inhibitors Reduce Vacuolar Swelling

In contrast to the effect of the chloride channel blockers, anandamide and quinidine caused vacuolar shrinking - but only when applied with Zn^2+^ (**Figure [3B](#F3){ref-type="fig"}**). Anandamide with Zn^2+^ was the most effective condition, causing a reduction in vacuolar area from 13.9 to 12.8 μm^2^, while the median vacuolar area of quinidine with Zn^2+^ was 13.2 μm^2^. This suggests that an osmotically active ion is being prevented from entering the vacuole.

Testing the Effect of Ion Channel Inhibitors on the Respiratory Burst of Human Neutrophils
------------------------------------------------------------------------------------------

### Chloride Channel Inhibitors Decrease the Respiratory Burst Only When Applied with Zn^2+^

To determine if the drop in vacuolar pH caused by DCPIB and FFA was due to direct inhibition of the NADPH oxidase, the respiratory burst was measured by recording oxygen consumed after phagocytosis of opsonized heat-killed *Candida* particles (**Figure [4](#F4){ref-type="fig"}**). Neither drug had a statistically significant effect on oxidase activity, although the percentage mean oxygen consumed was slightly lower than control cells: DCPIB 91.8% (SEM ± 5.2%), while FFA marginally decreased it further (90.6 ± 1.5%). However, the respiratory burst activity was considerably diminished when the drugs were incubated with Zn^2+^: DCPIB plus Zn^2+^ induced a drop to 37.7% (± 7.9%, *p* = 0.01), while the effect was less pronounced with FFA with Zn^2+^ (60.2 ± 5.1%, *p* = 0.038). These results suggest that blockage of HVCN1 and Cl^-^ channel/s together markedly impaired charge compensation.

![**The effect of DCPIB, FFA, anandamide, and quinidine with and without Zn^2+^ on human neutrophil oxygen consumption during phagocytosis of opsonized *Candida* particles.** The columns represent the mean of 3 experiments as a percentage of neutrophils incubated with the vehicle only, with error bars showing the standard error. Differences from control neutrophils: ^∗^*p* \< 0.05, ^∗∗∗^*p* \< 0.001. Differences from neutrophils incubated with Zn^2+^: †*p* \< 0.05, ††*p* \< 0.01. D (DCPIB 20 μM), F (FFA 100 μM), A (anandamide 100 μM), Q (quinidine 100 μM), Zn (Zn^2+^ 100 μM).](fphar-08-00094-g004){#F4}

### Potassium Channel Inhibitors Only Significantly Decrease the Respiratory Burst When Applied with Zn^2+^

Anandamide and quinidine had different effects on vacuolar pH and area from the chloride channel inhibitors, but the effect on respiratory burst activity was fairly similar (**Figure [4](#F4){ref-type="fig"}**). With anandamide, oxygen consumed increased slightly to 111% (±8.0%, *p* = ns) whereas quinidine produced a small but significant effect with a drop of mean O~2~ consumption to 80.3% (±3.8%, *p* = 0.02). Zn^2+^ alone reduced respiration to about 70% of control as previously reported ([@B12]) whereas in combination with anandamide or quinidine it further decreased respiration, falling to 33.6% (±6.4%, *p* = 0.005) and 42.9% (±3.3%, *p* = 0.01) respectively.

Vacuolar pH and Areas of Neutrophils from Genetically Modified Mice
-------------------------------------------------------------------

### Single and Double Knockout Mice Tested have Grossly Normal Vacuolar pH and Area

ClC3 was found to be significantly expressed in the neutrophil mRNA composite data (**Table [4](#T4){ref-type="table"}**), and regarded by some (as discussed in the introduction) to be involved in neutrophil oxidase charge compensation ([@B53]). We found no abnormalities in the vacuolar pH for ClC3^-/-^, but HVCN1^-/-^/ClC3^-/-^ neutrophils had a slightly higher vacuolar pH (**Figure [5A](#F5){ref-type="fig"}**). Additionally, the difference between the HVCN1^-/-^ control and double knockout was only 0.1 pH unit (see **Table [5A](#T5){ref-type="table"}** for exact statistics). The vacuolar area was not significantly different between either condition (**Figure [5B](#F5){ref-type="fig"}**).

###### 

A compilation of the averaged results of nine online datasets of mRNA expression in neutrophils.

  Gene symbol                                 Gene description                                                           Relative expression (Human)   Human       Mouse
  ------------------------------------------- -------------------------------------------------------------------------- ----------------------------- ----------- -----------
  **Oxidase components**                                                                                                                                           
  NCF2                                        Neutrophil cytosolic factor 2                                              98.50                                     
  CYBA                                        Cytochrome b-245, alpha polypeptide                                        86.79                                     
  NCF4                                        Neutrophil cytosolic factor 4, 40 kDa                                      94.99                                     
  CYBB                                        Cytochrome b-245, beta polypeptide                                         61.05                                     
  HVCN1                                       Hydrogen voltage-gated channel 1                                           78.57                                     
  **Chloride channels**                                                                                                                                            
  CLIC1                                       Chloride intracellular channel 1                                           95.92                         [@B5]       ^∗^
  BEST1                                       Bestrophin 1                                                               59.91                         ^∗^[@B18]   
  CIC7                                        Chloride channel, voltage-sensitive 7                                      41.53                         ^∗^[@B22]   ^∗^
  ClC3                                        Chloride channel, voltage-sensitive 3                                      35.36                         [@B53]      ^∗^[@B53]
  **Potassium channels**                                                                                                                                           
  KCNJ15                                      Potassium inwardly-rectifying channel, subfamily J, member 15              93.69                                     ^∗^
  KCNE3                                       Potassium voltage-gated channel, Isk-related family, member 3              77.44                         [@B7]       ^∗^
  KCNJ2                                       Potassium inwardly-rectifying channel, subfamily J, member                 80.66                         ^∗^[@B81]   [@B46]
  KCNQ1                                       Potassium voltage-gated channel, KQT-like subfamily, member 1              48.37                                     ^∗^
  KCNAB2                                      Potassium voltage-gated channel, shaker-related subfamily, beta member 2   43.76                                     
  KCNK7                                       Potassium channel, subfamily K, member 7                                   41.97                                     
  KCNH7                                       Potassium voltage-gated channel, subfamily H (eag-related), member 7       32.57                                     
  KCNH3                                       Potassium voltage-gated channel, subfamily H (eag-related), member 3       7.02                                      
  **Transient receptor potential channels**                                                                                                                        
  TRPM6                                       Transient receptor potential cation channel, subfamily M, member 6         31.06                                     
  MCOLN1                                      Mucolipin 1                                                                31.60                         ^∗^[@B6]    
  TRPV2                                       Transient receptor potential cation channel, subfamily V, member 2         17.94                                     ^∗^[@B43]
  TRPV6                                       Transient receptor potential cation channel, subfamily V, member 6         11.15                         [@B26]      
  **Solute carriers**                                                                                                                                              
  SLC12A6 (KCC3)                              Solute carrier family 12 (potassium/chloride transporters), member 6       92.47                         [@B77]      ^∗^[@B77]
  SLC26A6                                     Solute carrier family 26, member 6                                         29.45                                     ^∗^[@B29]
  SLC12A4 (KCC1)                              Solute carrier family 12 (potassium/chloride transporters), member 4       14.34                                     

Genes were ranked on relative mean expression levels; a more detailed explanation for acquiring the data is described in the methods. Expression levels of components of the neutrophil NOX2 oxidase system, gp91phox, p22phox, NCF1, NCF2, and HVCN1 are shown for comparison. The table has been edited to show channels linked to neutrophils, NOX systems or other immune cells in the literature. Asterisks denote which genetic models we have tested. Shaded rows indicate genetic models not yet investigated. The source of each data set can be found in Supplementary Table

S5

, while the full list of gene expression can be viewed in Supplementary Table

S6

. We also tested CFTR, ClC4, TRPA1, TRPC1, TRPC3, TRPC5, TRPC6, TRPM2, and TRPV1 for which expression levels were very low or non-existent.

![**Vacuolar pH (A)** and area **(B)** measured in the single knockout ClC3^-/-^ mice, and in the double knockout HVCN1^-/-^/ClC3^-/-^ mice. Each square represents an individual measurement with an overlaying boxplot showing the median and interquartile range. The SFR cut-off value for the HVCN1^-/-^ and double knockout mice was 2.23. See **Table [5](#T5){ref-type="table"}** for more detailed statistics. Differences from control neutrophils: ^∗^*p* \< 0.05.](fphar-08-00094-g005){#F5}

###### 

Vacuolar pH **(A)** and area **(B)** experimental measurements and statistics for the knockout mouse models presented in **Figures [5](#F5){ref-type="fig"}**--**[8](#F8){ref-type="fig"}**.

  \(A\) Vacuolar SNARF ratio                                                                                                                                                                         
  ---------------------------- ------------- ------------------- ----------------------------- ----------------------- ----------------------- ------------------------------ --------------- ------ --------------
  **N**                        **Control**   **No. of points**   **Control median (SFR/pH)**   **Knockout**            **No. of points**       **Knockout median (SFR/pH)**   ***p*-value**          
                                                                                                                                                                                                     
  3                            Wt            1269                0.9                           7.5                     ClC3^-/-^               1116                           0.9             7.5    0.268
  2                            HVCN1^-/-^    1130                3.6                           11.1                    HVCN1^-/-^/ClC3^-/-^    1157                           3.7             11.2   0.020
  4                            Wt            1637                0.9                           7.4                     KCC3^-/-^               1340                           0.9             7.5    2.0 × 10^-4^
  3                            HVCN1^-/-^    383                 2.8                           9.8                     HVCN1^-/-^/KCC3^-/-^    472                            2.8             9.9    0.165
  3                            Wt            589                 1.2                           8.0                     CLIC1^-/-^              780                            1.2             8.0    0.598
  3                            HVCN1^-/-^    1594                3.5                           10.8                    HVCN1^-/-^/CLIC1^-/-^   1596                           3.5             10.8   0.174
  3                            Wt            371                 1.0                           7.8                     TRPM2^-/-^              399                            1.0             7.8    0.087
  1                            HVCN1^-/-^    118                 1.9                           9.0                     HVCN1^-/-^/TRPM2^-/-^   82                             1.8             8.9    0.120
  3                            Wt            898                 1.0                           7.8                     KCNJ15^-/-^             727                            1.1             7.9    0.016
                                                                                                                                                                                                     
  **(B) Vacuolar area**                                                                                                                                                                              
                                                                                                                                                                                                     
  **N**                        **Control**   **No. of points**   **Control median (±*SD*)**    **Knockout**            **No. of points**       **Knockout median (±*SD*)**    ***p*-value**          
                                                                                                                                                                                                     
  3                            Wt            281                 10.8 (4.9)                    ClC3^-/-^               273                     11.2 (4.5)                     0.650                  
  2                            HVCN1^-/-^    549                 13.4 (6.7)                    HVCN1^-/-^/ClC3^-/-^    570                     14.2 (6.1)                     0.109                  
  3                            Wt            445                 11.2 (3.4)                    KCC3^-/-^               458                     11.3 (3.9)                     0.469                  
  3                            HVCN1^-/-^    389                 16.7 (6.4)                    HVCN1^-/-^/KCC3^-/-^    287                     17.3 (5.5)                     0.554                  
  3                            Wt            266                 12.9 (4.2)                    CLIC1^-/-^              346                     13.2 (4.5)                     0.167                  
  3                            HVCN1^-/-^    696                 15.1 (7.4)                    HVCN1^-/-^/CLIC1^-/-^   650                     12.8 (6.8)                     6.7x10^-7^             
  3                            Wt            162                 11.7 (5.3)                    TRPM2^-/-^              208                     11.0 (5.1)                     0.569                  
  1                            HVCN1^-/-^    78                  17.1 (9.9)                    HVCN1^-/-^/TRPM2^-/-^   39                      18.7 (11.4)                    0.830                  
  3                            Wt            633                 9.9 (3.9)                     KCNJ15^-/-^             387                     10.4 (4.6)                     0.003                  

N = number of experiments performed, no. of points describes the total number of individual measurements. The control and corresponding knockout medians are accompanied with the SFR and converted vacuolar pH and standard deviation (SD) for the vacuolar area.

No significant change in vacuolar area was found for either KCC3^-/-^ or HVCN1^-/-^/KCC3^-/-^ (**Figure [6A](#F6){ref-type="fig"}**), but the vacuolar pH was slightly increased in the single knockouts (**Figure [6B](#F6){ref-type="fig"}**), from ∼ pH 7.4 to 7.5.

![**Vacuolar pH (A)** and area **(B)** measured in the single knockout KCC3^-/-^ mice, and in the double knockout HVCN1^-/-^/KCC3^-/-^ mice. Each square represents an individual measurement with an overlaying boxplot showing the median and interquartile range. A small difference was found between the vacuolar pH of WT and KCC3^-/-^ neutrophils which was statistically significant (^∗∗∗^*p* \< 0.001). The SFR cut-off value for the HVCN1^-/-^ and double knockout mice was 1.31.](fphar-08-00094-g006){#F6}

While CLIC1 has not been directly linked to neutrophil oxidase activity, it is thought to be involved with lysosomal acidification in macrophages ([@B34]), and it was highly expressed in the composite expression data (**Table [4](#T4){ref-type="table"}**). We found no change in vacuolar pH in either model compared to the wild type (WT) or HVCN1^-/-^ controls (**Figure [7A](#F7){ref-type="fig"}**), but there was a highly significant decrease in vacuolar area in the HVCN1^-/-^/CLIC1^-/-^ neutrophils; the median decreased from 15.1 μm^2^ to 12.8 μm^2^.

![**Vacuolar pH (A)** and area **(B)** measured in the single knockout CLIC1^-/-^ mice, and in the double knockout HVCN1^-/-^/CLIC1^-/-^ mice. Each square represents an individual measurement with an overlaying boxplot showing the median and interquartile range. The SFR cut-off value for the HVCN1^-/-^ and double knockout mice was 2.20. Difference between HVCN1^-/-^ and HVCN1^-/-^/CLIC1^-/-^: ^∗∗∗^*p* \< 0.001.](fphar-08-00094-g007){#F7}

TRPM2 has been cited as being important in negative feedback of the NADPH oxidase, yet we could find no abnormalities in either vacuolar pH or area for the single knockout or double knockout (HVCN1^-/-^/TRPM2^-/-^) mice (see **Figure [8](#F8){ref-type="fig"}**).

![**Vacuolar pH (A)** and area **(B)** measured in the single knockout KCNJ15^-/-^ mice, single knockout TRPM2^-/-^ mice, and in the double knockout HVCN1^-/-^/TRPM2^-/-^ mice. The SFR cut-off value for the HVCN1^-/-^ and double knockout mice was 1.197. A (WT used for KCNJ15^-/-^), B (KCNJ15^-/-^), C (WT used for TRPM2^-/-^), D (TRPM2^-/-^), E (HVCN1^-/-^), F (HVCN1^-/-^/TRPM2^-/-^). Differences between WT and KCNJ15^-/-^ neutrophils: ^∗^*p* \< 0.05, ^∗∗^*p* \< 0.01.](fphar-08-00094-g008){#F8}

Because the inhibitor studies indicated that Cl^-^ and cation channels were likely to be involved in charge compensation we decided to test those most highly expressed in neutrophils as shown in **Table [4](#T4){ref-type="table"}**. We did not find anything that was significantly abnormal in these other knockout mouse models (although some were only tested once, further details in Supplementary Tables [3A,B](#SM3){ref-type="supplementary-material"}), apart from mice lacking KCNJ15. The vacuolar area appeared to be marginally increased in the knockout mice (**Figure [8](#F8){ref-type="fig"}**, *p* \< 0.01). The vacuolar pH for KCNJ15^-/-^ neutrophils was 0.1 pH unit higher than WT controls (*p* \< 0.05).

### Respiratory Burst Activity in Knockout Mouse Neutrophils

We confined our investigations of oxidase activity to mouse models that had either demonstrated a difference in vacuolar pH or area or had previously been cited to have an abnormality in the respiratory burst. The respiratory burst had previously been described as abnormally low in ClC3^-/-^ and KCC3^-/-^ neutrophils ([@B53]; [@B77]) and in CLIC1^-/-^ macrophages ([@B34]).

In the ClC3^-/-^ neutrophils, respiration had been found to be particularly compromised when they were stimulated with opsonised zymosan, a phagocytic stimulus, rather than the soluble agonist PMA ([@B53]) although total oxidase response was also reduced with this agent. We were unable to reproduce this effect - we found that oxygen consumption induced by both PMA and the phagocytosis of heat-killed *Candida* in the knockout neutrophils was no different from control neutrophils (**Figure [9](#F9){ref-type="fig"}**).

![**Measuring oxygen consumption in ClC3, KCC3, CLIC1, TRPM2, and HVCN1 deficient mouse peritoneal neutrophils induced by PMA (blue) and opsonized *Candida* (red).** Oxygen consumption (OC) is presented as a relative percentage of the wild-type control (mean ± SEM). The numbers below indicate the number of separate experiments in brackets and number of wells recorded. Differences from WT neutrophils within each experiment: ^∗^*p* \< 0.05, ^∗∗^*p* \< 0.01, ^∗∗∗^*p* \< 0.001. The statistics for HVCN1^-/-^/CLIC1^-/-^ neutrophils are compared to HVCN1^-/-^ controls where ††*p* \< 0.01.](fphar-08-00094-g009){#F9}

We confirmed that the KCC3^-/-^ mouse neutrophils did have abnormal oxidase activity ([@B77]). The oxygen consumed is reduced to 53%, and 63% of normal after stimulation with PMA or opsonized *Candida* respectively. Oxidase activity in HVCN1^-/-^ neutrophils was again about half of normal ([@B39]).

The respiratory burst of neutrophils from both CLIC1^-/-^ and HVCN1^-/-^/CLIC1^-/-^ mice was greater than normal: for CLIC1^-/-^ approximately 242% (±53%) of WT control, and 86% (±14%) and 64% (±4%) for PMA and *Candida* stimulate respiration by HVCN1^-/-^/CLIC1^-/-^ neutrophils. These measurements were only made once on the CLIC1^-/-^ and twice on the HVCN1^-/-^/CLIC1^-/-^ mice. Although four wells were measured with each of the stimuli in both the control and knock-out mice the results must be interpreted with this caveat. The respiratory burst certainly did not appear to be depressed as it was in CLIC1^-/-^ macrophages ([@B34]).

While we had found no differences in vacuolar pH and area between WT and TRPM2^-/-^ neutrophils, we wanted to assess the NOX2 activity as it has been reported that TRPM2 deficient neutrophils and macrophages have an increased production of reactive oxygen species ([@B15]). We measured the PMA-induced oxygen consumption was 117% of the WT control, and *Candida*-induced oxygen consumption was 86% of WT control, which do not resemble the 2- to 3-fold increase reported by Di and co-workers in both conditions.

Vacuolar pH and Area in Neutrophils of Patients with Channelopathies Appear Normal in CF Patients
-------------------------------------------------------------------------------------------------

While it has been noted previously that patients with CF have abnormal neutrophil oxidase activity ([@B8]), we could find no abnormality in the vacuolar pH and area (**Figure [10](#F10){ref-type="fig"}**). We also measured cytoplasmic pH in reference to one claim that found abnormally high cytoplasmic pH in CF patients ([@B10]) -- again, we did not replicate this finding (Supplementary Table [S4](#SM4){ref-type="supplementary-material"}).

![**Vacuolar pH (A)** and area **(B)** from two patients with cystic fibrosis (CF) with and without 300 μM zinc. Both patients were tested only once. Acidic vacuoles with a SFR value less than 1.2 were excluded. Between 120 and 440 vacuoles were counted for vacuolar pH, between 238 and 304 for the vacuolar area. No differences were observed between the healthy controls and the patients' vacuolar parameters.](fphar-08-00094-g010){#F10}

The vacuolar pH and area were also measured twice in two patients with mutations in the Bestrophin1 gene: patient 1 had total allelic deletion, while patient 2 had a deletion and a missense mutation in the other allele. Patient 1 had no detectable abnormalities in the vacuolar parameters, while for patient 2, the vacuolar area was larger with and without Zn^2+^. Two patients were tested with Albers-Schönberg disease or autosomal dominant osteopetrosis, caused by a mutation in ClC7. Patient 1 had lower vacuolar pH only with Zn^2+^, while patient 2 with Zn^2+^ had reduced vacuolar area, but the results on the whole were not grossly abnormal. Only one patient was tested once with the disorder in the MCOLN1 gene, or Mucolipidosis type IV, and had no significant changes in either parameter (Supplementary Table [S5](#SM5){ref-type="supplementary-material"}).

Discussion
==========

In order to identify the ion channels contributing to charge compensation in neutrophils, we have investigated the effects of known channel inhibitors and examined knockout mice and patients with non-functioning channels.

There has been considerable interest in the role of chloride channels in neutrophil function because of the belief that myeloperoxidase generates HOCl in this compartment, although this mechanism has been contested ([@B40]). The generation of HOCl would require the movement of Cl^-^ into the vacuole, which would be against the electrochemical gradient generated by the passage of electrons into the vacuole through NADPH oxidase. Neutrophils have a particularly high resting cytosolic concentration of Cl^-^; approximately 80 meq/L or 80 mM ([@B73]). After stimulation by soluble agonists ([@B88]) or phagocytosis ([@B9]), they release large quantities of Cl^-^ into the extracellular medium ([@B50]), which is thought to adjust for phagocytosis-induced cellular swelling ([@B76]).

The classical broad spectrum Cl^-^ channel blockers, DCPIB and FFA both produced vacuolar acidification without inhibiting oxidase activity implying that they were preventing the efflux of Cl^-^ from the vacuole -- it is known that DPI, an inhibitor of the oxidase, causes vacuolar acidification ([@B31]). FFA caused a slight increase in vacuolar volume, suggesting that it might be trapping Cl^-^ in the vacuole, although this was not the case for DCPIB. In the presence of Zn^2+^, which blocks proton channels, both these inhibitors induced vacuolar swelling more so than zinc alone and despite diminished oxidase activity, suggesting that the additional swelling resulted from the influx of non-proton cations, K^+^ and/or Na^+^. The effects observed with chloride channel inhibitors suggest that it is more likely that Cl^-^ will be passing out of the vacuole to compensate the charge than into it as the substrate for the generation of HOCl.

However, although primarily thought of as blockers of Cl^-^ channels, DCPIB and FFA are rather non-specific -- as demonstrated in **Table [1](#T1){ref-type="table"}**. DCPIB was first described as a "potent and selective" inhibitor of the swell-activated chloride current ICI~swell~ ([@B11]), or of the volume-regulated anion channel (VRAC), which is thought to participate in regulatory volume decrease (RVD) under certain physiological conditions. However, other DCPIB-sensitive ion channels have been reported. Sites of inhibition include inwardly rectifying K^+^ channels ([@B13]), and the K^+^/Cl^-^ co-transporter KCC3 ([@B1]), while it has been shown to activate the 2P K^+^ channels TREK-1 and TREK-2 ([@B52]). There is evidence that it has no effect on CFTR ([@B11]). FFA blocks ICI~swell~ ([@B35]), CFTR ([@B47]) (but at a higher concentration than used in these studies), CLIC1 ([@B41]) and calcium-activated Cl^-^ channels ([@B57]), and some TRP channels ([@B24]). Both FFA and DCPIB open 2P K^+^ channels TWIK-1 and TWIK-2 ([@B78]).

We thus attempted to identify a specific Cl^-^ channel by examining the function of neutrophils from humans and mice in which such channels were defective.

Two channels, in particular, have been proposed as conducting Cl^-^ into the vacuole; CFTR ([@B59]) and ClC3 ([@B56]; [@B83]). [@B59] described that the killing of *Pseudomonas aeruginosa* by neutrophils was impaired in cells from patients with CF and by normal neutrophils treated with GlyH-101, which they took to be a specific inhibitor of CFTR. They found bacterial killing to be marginally reduced by the CF patient's cells and after treatment with 50 μM GlyH-101 ([@B58]). However, the experiment was conducted in Cl^-^ free extracellular medium for the first 10 min, and the effect of such treatment on CF cells was not established. In addition, [@B49] found that GlyH-101 used at 50 μM reduced cell viability by over 50%. They also found that GlyH-101 almost completely blocked other Cl^-^ conductances including the volume-sensitive outwardly rectifying Cl^-^ conductance (VSORC) and Ca^2+^-dependent Cl^-^ conductance when used at 10 μM. We found no abnormalities neutrophils from CF patients with the common ΔF508 mutation, which argues against an essential role for this channel in charge compensation of the oxidase. [@B49] also demonstrated that the pharmacological inhibitor, CFTR inh-172, is not specific so the small downward shift in vacuolar pH of human and HVCN1^-/-^ mouse neutrophils (Supplementary Table [S5](#SM5){ref-type="supplementary-material"}) produced by this agent is likely to be due to an off-target effect in the light of the normal results obtained with CF patient cells. We found no evidence of significant levels of expression of CFTR in the archival neutrophil mRNA expression data, but there is evidence for its expression in neutrophils, albeit at very low levels ([@B60]; [@B48]).

[@B53] observed that neutrophils from ClC3 knock-out mice displayed markedly reduced NADPH oxidase activity in response to opsonized zymosan and modestly reduced activity after phorbol 12-myristate 13-acetate and thus inferred that ClC3 participates in charge compensation, although they did not provide a clear mechanism by which this might be achieved. We found oxidase activity in ClC3 knock-out mice to be entirely normal after stimulation with opsonized *Candida* or with PMA One difference between our experiments and those of [@B53] was that they used a chemiluminescence assay to measure superoxide production, whereas we measured oxygen consumption directly. Of perhaps more consequence is that we used ClC3^-/-^ mice generated by a different method to [@B53]: our mice were generated by Jentsch and colleagues ([@B75]) in which exon 3 was deleted, causing complete ablation of the gene in the resulting mice when tested with an antibody targeted to the N-terminus of the ClC3 gene made in-house. In contrast, part of exon 6 and all of exon 7 was removed in the other knockout mouse model, and the absence of the gene protein was tested using a commercial antibody targeted at the C-terminus ([@B16]) that [@B75] advised against using.

We found no impairment of vacuolar pH in CLIC1^-/-^ or HVCN1^-/-^/CLIC1^-/-^ bone marrow-derived neutrophils, as it has been noted in CLIC1^-/-^ peritoneal macrophages ([@B34]) and bone marrow-derived dendritic cells ([@B69]). Most of the charge compensation of the neutrophil oxidase is conducted through the HVCN1 channel. We made the double KO mice because, although the HVCN1 proton channel is blocked by 100 μM Zn^2+^, this effect is only partial as evidenced by the relatively poorly elevated pH and vacuolar volume in Zn^2+^ treated cells as compared with HVCN1^-/-^ cells.

Instead, we observed a slight but significant decrease in vacuolar area in the double knockout HVCN1^-/-^/CLIC1^-/-^ mice compared to the HVCN1^-/-^ controls. We also tested oxidase activity in the double knockout mouse; oxygen consumption was significantly raised in the double knockout compared to HVCN1^-/-^ controls. If CLIC1 helps to compensate V-ATPase activity by matching proton influx with chloride influx on granule and phagosomal membranes, then its deletion might reduce water influx, and consequently vacuolar area, as was observed. Further investigation is necessary to confirm these results.

ICI~swell~, or the VRAC ([@B32]), is blocked by three of the four Cl^-^ channel inhibitors we found to reduce vacuolar pH (**Table [2](#T2){ref-type="table"}**). Cells from a mouse in which LRRC8A was non-functional (Behe et al) had no effect on neutrophil vacuolar pH or volume, or on the respiratory burst.

There is also evidence that the entry of K^+^ into the phagocytic vacuole is driven by activity of the oxidase ([@B66]) and the enhanced swelling of the vacuole induced by DCPIB and FFA described above could reflect the augmented entry of this ion induced by these agents when Cl^-^ efflux is replaced by K^+^ influx. We thus examined the effect of K^+^ channel blockers. The broad spectrum blockers, anandamide and quinidine, did change vacuolar conditions. Anandamide caused a decrease in both vacuolar pH and area, without inhibiting oxidase activity, suggesting that it was blocking the influx of non-proton cations. Their effects were exaggerated by the presence of Zn^2+^ which led to a halving of oxygen consumption. In contrast, quinidine reduced vacuolar volume but not pH, suggesting that it is a more selective inhibitor of K^+^ influx. It also had an effect on respiration, reducing it by about 20%. Anandamide is slightly more selective than quinidine, inhibiting the two-pore domain (2P) K^+^ channels TASK-1 (KCNK3) ([@B45]) and TASK-3 (KCNK9) ([@B3]), and some voltage-dependent K^+^ channels ([@B62]; [@B54]). Of particular interest is the claim made by [@B38] that NOX4 modulates TASK-1 activity in oxygen-sensing cells. Perhaps it is similarly modulated by NOX2 in neutrophils. Quinidine is a relatively non-specific blocker of both Na^+^ ([@B28]) and K^+^ channels (calcium-activated ([@B89]; [@B85]), indicates that changes induced by quinidine do not distinguish between K^+^ and Na^+^, but prior knowledge ([@B66]) supports the likelihood that it is K^+^ that is passing into the vacuole. Quinidine also blocks voltage-gated ([@B80]; [@B4]), and two-pore domain ([@B61]; [@B86]; [@B3]) K^+^ channels, as well as the swell activated chloride current ICI~swell~ ([@B82]).

We then tested a wide range of more specific K^+^ channel inhibitors to try to identify the K^+^ channel, but none of these induced significant alterations in vacuolar conditions.

Once again, we examined several knock-out mice lacking specific K^+^ channels which were selected according to expression levels in human neutrophils and included KCNQ1, KCNE3, KCNJ2, KCNJ15, and various TRP channel-deficient mice. Transient receptor potential (TRP) channels are unselective for cations, a few of which have been associated with neutrophil function, including TRPC1 ([@B42]) and TRPM2 ([@B25]). TRPM2 has been described as a negative feedback mechanism to prevent excess ROS produced by the NADPH oxidase in phagocytes ([@B15]) by regulating vacuolar membrane depolarisation through Ca^2+^ and Na^+^ ionic movement. We could not reproduce the enhanced respiratory burst reported in TRPM2^-/-^ mouse neutrophils ([@B15]) and we found no changes in the vacuolar pH and area compared to controls. TRP channel blockers, such as amiodarone and SKF96365 ([@B79]), were tested but were also without effect.

KCC3^-/-^ mice have been shown to have an impairment of NADPH oxidase activity with diminished bacterial killing ability ([@B77]), which we confirmed using the Seahorse assay instead of the lucigenin-enhanced chemiluminescence assays they employed, but were unable to detect alterations in vacuolar pH or area.

In summary, the broad spectrum channel blockers, DCPIB and FFA, anandamide and quinidine, affect vacuolar physiology by altering pH and cross-sectional area in different ways. DCPIB and FFA are largely considered to block Cl^-^ channels and their effects were consistent with charge compensation by the efflux of this ion from the vacuole. In contrast, anandamide and quinidine are largely considered to be blockers of K^+^ channels and their effects were consistent with the oxidase-induced flux of K^+^ into the vacuole. Even so, these inhibitors are not highly ion specific and the results must be interpreted with this in mind. Our inability to identify individual channels in these processes could result from our selection of the wrong selective inhibitors or knock-out animals or there might be considerable redundancy in the system, and for example the loss of a channel might result in exaggerated membrane depolarization to a level that would then open another voltage-gated channel that would not normally participate in physiological charge compensation. However, the effects of the four stated ion channel blockers confirm that fluxes of ions other than protons are important for the regulation of vacuolar pH and area neutrophil phagosomes.
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